The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Ketoconazole as inhibitor of the enzyme CYP17 in locally advanced or disseminated granulosa cell tumors of the ovary (the GreKo I study) (gethi 11-03).
Laia Garrigos
No relevant relationships to disclose
Alicia Hurtado
No relevant relationships to disclose
Ana Santaballa
No relevant relationships to disclose
Andrés Redondo
No relevant relationships to disclose
Nuria Laínez
No relevant relationships to disclose
Laura Vidal Boixader
No relevant relationships to disclose
Eva Guerra Alia
No relevant relationships to disclose
Victor Rodriguez
No relevant relationships to disclose
Juan Fernando Cueva
No relevant relationships to disclose
Isabel Bover
No relevant relationships to disclose
Isabel Palacio
No relevant relationships to disclose
M Jesus Rubio
No relevant relationships to disclose
Mario Prieto
No relevant relationships to disclose
Jose Antonio Lopez-Guerrero
No relevant relationships to disclose
Nuria Romero
No relevant relationships to disclose
Zaida Garcia-Casado
No relevant relationships to disclose
Elena García-Martínez
No relevant relationships to disclose
Enrique Grande
No relevant relationships to disclose
Jesús García-Donas
No relevant relationships to disclose